-- 
Mazor Advances Most Since October on FDA Approval of 3D System

-- B y   S h o s h a n n a   S o l o m o n
-- 
2011-12-05T09:26:35Z

-- http://www.bloomberg.com/news/2011-12-05/mazor-advances-most-since-october-on-fda-approval-of-3d-system.html
Mazor Robotics Ltd. (MZOR)  rose the most in
almost two months after it received approval from the U.S. Food
and Drug Administration for the three dimensional use of its
Renaissance system.  Shares in the developer of surgical robots surged 8.8
percent, the biggest intraday gain since Oct. 17, to 4.227
shekels at 11:16 a.m. in  Tel Aviv .  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  